PDUFA dates April 2016: FDA calendar and catalysts.
0 PDUFA dates fell in April 2016. The FDA calendar also recorded 7 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in April 2016
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
April 2016: other FDA decisions and filings
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| April 4, 2016 | Descovy (emtricitabine; tenofovir alafenamide fumarate) | GILD | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 11, 2016 | Venclexta (venetoclax) | ABBV | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 15, 2016 | Photrexa Viscous In Dextran 20% (riboflavin 5'-phosphate; riboflavin 5'-phosphate sodium) | GKOS | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 25, 2016 | Bevespi Aerosphere (formoterol fumarate; glycopyrrolate) | AZN | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 25, 2016 | Cabometyx (cabozantinib s-malate) | EXEL | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 25, 2016 | Triferic Avnu (ferric pyrophosphate citrate) | RMTI | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 28, 2016 | Phexx (citric acid; lactic acid; potassium bitartrate) | EVFM | Complete Response Letter | — | CRL issued | FDA Complete Response Letters |
April 2016: dated readouts
No events in this view.
Questions
What PDUFA dates are in April 2016?
0 PDUFA dates fell in April 2016. The FDA calendar also recorded 7 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.